Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: Comparing questionnaire results with in-depth interviews

American Journal of Medical Genetics

Volumn 75, Issue 1, 1998, Pages 62-74

  DudokdeWit, A Christine ^a,c   Tibben, Aad ^a,c   Duivenvoorden, Hugo J ^a   Niermeijer, Martinas F ^b   Passchier, Jan ^a   Trijsburg, R Willem ^a   Lindhout, D ^b   Meijers Heijboer, E J ^b   Frets, P G ^b,d   Lodder, L N ^d   Zoetewij, M W ^d   Klijn, J G M ^b   Brocker Vriends A ^d   Van Haeringen, A ^d   Helderman, A T J M ^d   Hilhorst Hofstee, Y ^d   Kant, S ^d   Maat Kievit, J A ^d   Oosterwijk, J C ^d   Van Der Smagt, J J ^d   Vegter Van Der Vlis, M ^d   Vries Van Der Weird, M A C S ^d   Zoeteweij, M W ^d   Bakker, E ^d   Devilee, P ^d   Losekoot, M ^d   Tops, C ^d   Cornelisse, C J ^d   Vasen, H F A ^e   more..

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Clinical Genetics ^*  (Netherlands)

^e Netherlands Foundation for the Detection of Hereditary Tumors   (Netherlands)

Author keywords

Genetic counseling; Hereditary cancer syndromes; Neurodegenerative disorders; Predictive DNA test

Indexed keywords

AMYLOIDOSIS; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FAMILIAL COLON POLYPOSIS; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MENTAL STRESS; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE;

ADENOMATOUS POLYPOSIS COLI; AGE OF ONSET; ANXIETY; BREAST NEOPLASMS; CEREBRAL HEMORRHAGE; DEPRESSION; FEMALE; GENES, DOMINANT; GENETIC COUNSELING; GENETIC DISEASES, INBORN; HUMANS; HUNTINGTON DISEASE; INTERVIEW, PSYCHOLOGICAL; MALE; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL;

EID: 0031974321     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980106)75:1<62::AID-AJMG14>3.0.CO;2-Q     Document Type: Article

References (88)

1. Almqvist E, Bloch M (1996): "World-wide Survey on Catastrophic Events Following Predictive Testing for Huntington Disease." San Francisco: American Society of Human Genetics.
2. Arrindell WA, Ettema JHM (1986): "SCL'90; Handleiding bij een multidimensionele psychopathologie-indicator" (manual). Lisse: Swets & Zeitlinger.
3. Bakker E, van Broeckhoven C, Haan J, Voorhoeve E, van Hul W, Levy E, Lieberburg I, Carman MD, van Ommen GJ, Frangione B, Roos RAC (1991): DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 49:518-521.
4. Beck AT, Steer RA (1989): Clinical predictors of eventual suicide: A 5- to 10-year prospective study of suicide attempts. J Affect Dis 17:203-209.
5. Beck AT, Weismann A, Lester D, Trexler L (1974): The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42:861-865.
6. Beck AT, Steer RA, Kovacs M, Garrison B (1985): Hopelessness and eventual suicide: A 10 year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatr 142:559-563.
7. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA (1990): Relationshipe between hopelessness and ultimate suicide: A replication with psychiatric outpatients. Am J Psychiatr 147:190-195.
8. Bird TD (1994): Familial Alzheimer's disease. Ann Neurol 36:335-336.
9. Bloch M, Fahy M, Fox S, Hayden MR (1989): Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 32:217-224.
10. Bloch M, Adam S, Wiggins S, Huggins M, Hayden MR (1992): Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk. Am J Med Genet 42:499-507.
11. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992): Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808.
12. Bruyn GW, Went LN (1986): Huntington's chorea. In Vinken PJ, Bruyn GW, Klawans HL (eds): "Handbook of Clinical Neurology. Extrapyramidal Disorders, Vol. 49." Amsterdam: Elsevier/North Holland, pp 267-313.
13. Bundey S (1997): Few psychological consequences of presymptomatic testing for Huntington disease. Lancet 349:4.
14. Channer KS, Papouchado M, James MA, Rees JR (1985): Anxiety and depression in patients with chest pain referred for exercise testing. Lancet 8459:820-823.
15. Codori AM, Brandt J (1994): Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 54:174-184.
16. Codori AM, Hanson R, Brandt J (1994): Self-selection in predictive testing for Huntington's disease. Am J Med Genet 54:167-173.
17. Codori AM, Slavney PR, Young C, Miglioretti DL, Brandt J (1997): Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol 16:36-50.
18. Cornelis RS, Vasen HF, Meijers-Heijboer EJ, Ford D, van Vliet M, van Tilborg AA, Cleton FJ, Klijn JG, Menko FH, Meera Khan P, Cornelisse CJ, Devilee P (1995): Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Hum Genet 95:539-544.
19. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J (1997): Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 16:63-72.
20. Decruyenaere M, Evers-Kiebooms G, Demyttenaere K, van den Berghe H (1994): Predictive testing for Huntington's disease in Flanders: Psychological characteristics of test applicants. Gedrag Gezondheid 22:238-247.
21. Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman JJ, Cloostermans T, Demyttenaere K, Dom R, Fryns JP, van den Berghe H (1995): Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Counsel 6:1-13.
22. Decruyenaere M, Evers-Keibooms G, Boogaerts A, Cassiman J-J, Cloostermans T, Demyttenaere K, Dom R, Fryns J-P, van den Berghe H (1996): Prediction of psychological functioning one year after the predictive test for Huntington's Disease and impact of the test result on reproductive decision making. J Med Genet 33:737-743.
23. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Coneally PM (1993): Suicide risk in Huntington's disease. J Med Genet 30:293-295.
24. Derogatis LR, Rickeis K, Roch FA (1976): The SCL-90 and the MMPI: A step in the validation of a new self-report scale. Br J Psychiatr 128: 280-289.
25. Dozier M, Kobak RR (1992): Psychophysiology in adolescent attachment interviews: Converging evidence for dismissing strategies. Child Dev 63:1473-1480.
26. Dozier M, Lee SW (1995): Discrepancies between self- and other-report of psychiatric symptomatology: Effects of dismissing attachment strategies. Dev Psychopathol 7:217-226.
27. Dozier M, Cue K, Barnett L (1994): Clinicians as caregivers: Role of attachment organization in treatment. J Consult Clin Psychol 62:793-800.
28. DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Niermeijer MF (1996): Males at-risk for the BRCA1-gene, the psychological impact. Psycho-Oncology 5:251-257.
29. DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JGM, Oostenvijk JC, Niermeijer MF (1997a): BRCA1 in the family: A case description of the psychological interaction. Am J Med Genet 71: 63-71.
30. DudokdeWit AC, Tibben A, Duivenvoorden HJ, Frets PG, Zoeteweij MW, Losekoot M, van Haeringen A, Niermeijer MF, Passchier J, Genetics Workgroup (1997b): Psychological distress in applicants of predictive DNA-testing for autosomal dominant inheritable late onset disorders. J Med Genet 34:382-391.
31. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993;52:678-701.
32. Evers A, van Vliet-Mulder JC, Ter Laak J (1992): "Documentatie van tests en testresearch in Nederland" [Documentation of tests and testresearch in the Netherlands]. Assen: van Gorchum.
33. Evers-Kiebooms G, Swerts A, van Den Berghe H (1990): Partners of Huntington patients: Implications of the disease and opinions about predictive testing and prenatal diagnosis. Genet Counsel 1:151-159.
34. Evers-Kiebooms G, Decruyeneare M, Fryns J-P, Demyttenaere K (1997): Psychological consequences of presymptomatic testing for Huntington's disease. Lancet 346:808.
35. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-695.
36. Grice HP (1975): Logic and conversation. In Cole P, Moran, JL (eds): "Syntax and Semantics." New York: Academic Press, pp. 41-58.
37. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R (1991): Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600.
38. Grossfeld FJM, Lips CJM, ten Kroode HFJ, Beemer FA, van Spijker HG, Brouwers-Smalbraak GJ (1996): Psychological consequences of DNA analysis for MEN type 2. Oncology 10:141-146.
39. Haan J, Roos RAC, Briet PE, Herpers MJ, Luyendijk W, Bots GT (1989): Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Research-Group Hereditary Cerebral Amyloid-Angiopathy. Clin Neurol Neurosurg 91:285-290.
40. Haltia M, Viitanen M, Sulkava R, Ala-Hurula V, Poyhonen M, Goldfarb L, Brown P, Levy E, Houlden H, Crook R, Goate A, Clark R, Korenblat K, Pandit S, Donis Keller H, Lilius L, Liu L, Axelman K, Forsell L, Winblad B, Lannfelt L, Hardy J (1994): Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description. Ann Neurol 36:362-367.
41. Harper PS (1991): "Huntington's Disease." London: Saunders Company.
42. Harper PS (1992): Ethical issues in genetic testing for Huntington's disease: Lessons for the study of familial cancers. Dis Markers 10:189-193.
43. Hayden MR (1981): "Huntington's Chorea." New York: Springer Verlag.
44. Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JGM, Vasen HF, Meijers-Heijboer EJ Menko FH, Cornelisse CJ, den Dunnen JT, Devilee P, van Ommen GJB (1995): Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet 10:208-212.
45. Horowitz MJ, Wilner N, Alvarez W (1979): Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218.
46. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky O, Trew M, Klimek M, Greenberg CR, Eleff M, Thompson LP, Knight J, MacLeod P, Girard K, Theilmann J, Hedrick A, Hayden MR (1992): Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42:508-515.
47. Huntington's Disease Collaborative Research Group (1993): A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
48. Jagelman D (1988): The expanding spectrum of familial adenomatous polyposis. Perspect Colon Rectal Surg 1:30-46.
49. Janis IL, Mahl GF, Kagan J, Holt RR (1969): "Personality: Dynamics, Development and Assessment." New York: Harcourt, Brace & World.
50. Kessler S, Bloch M (1989): Social system responses to Huntington disease. Fam Process 28:59-68.
51. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishishi I, Nakamura Y (1991): Identification of FAP locus genes from chromosome 5q21. Science 253:661-665.
52. Kobak RR (1988): Attachment in the late adolescence: Working models, affect regulation, and representation of self and others. Child Dev 59: 135-146.
53. Lerman C, Marshall J, Audrian J, Gomez-Caminero A (1996a): Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 69:58-61.
54. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996b): BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275:1885-1892.
55. Luborsky L (1975): Clinicians' judgements of mental health. Bull Menninger Clin 5:448-480.
56. Luborsky L, Diguer L, Luborsky E, McLellan AT, Woody G, Alexander L (1993): Psychological health-sickness as a predictor in dynamic and other psychotherapies. J Consult Clin Psychol 61:542-548.
57. Lynch HT, Watson P, Conway TA, Lynch JF, Slominski-Caster SM, Narod SA, Feunteun J, Lenoir G (1993): DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med 153:1979-1987.
58. Main M (1995): Recent studies in attachment: Overview, with selected implications for clinical work. In Goldberg S, Muir R, Kerr J (eds): "Attachment Theory: Social, Developmental and Clinical Perspectives." Hillsdale, NJ: Analytic Press.
59. Main M, Goldwyn R (in press): Adult Attachment classification system. In Main M (ed): "Assessing Attachment Through Discourse, Drawings and Reunion Situations." New York: Cambridge University Press.
60. Marteau T, Richards M (1996): "The Troubled Helix: Social and Psychological Implications of the New Human Genetics." Cambridge: University Press.
61. Michie S, McDonald V, Marteau T (1996): Understanding responses to predictive genetic testing: A grounded theory approach. Psychol Health 11:455-470.
62. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Allbright L, Goldgar D, Wiseman, R, Kamb A, Skolnick MH (1994): A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
63. Mlynik-Szmid A (1997): Psychological consequences of presymptomatic testing for Huntington's disease. Lancet 349:808.
64. Petersen GM (1994): Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med 26:205-208.
65. Petersen GM, Boyd PA (1995): Gene tests and counseling for colorectal cancer risks: lessons from familial polyposis. J Natl Cancer Inst Monogr 17:67-71.
66. Ponder M, Green JM (1996): BRCA1 testing: Some issues in moving from research to service. Psycho-Oncology 5:223-232.
67. Quaid KA (1993): Presymptomatic testing for Huntington disease in the United States. Am J Hum Genet 53:785-787.
68. Quaid KA, Wesson MK (1995): Exploration of the effects of predictive testing for Huntington disease on intimate relationships. Am J Med Genet 57:46-51.
69. Roos RAC, Vegter-van der Vlis M, Hermans J, Elshove HM, Moll AC, van de Kamp JJP, Bruyn GW (1991): Age at onset in Huntington's disease: Effect of line of inheritance and patient's sex. J Med Genet 28:515-519.
70. Roos RAC, Hermans J, Vegter-van der Vlis M, van Ommen GJB, Bruyn GW (1992): Duration of ilness in Huntington's disease is not related to age of onset. J Neurol Neurosurg 56:98-100.
71. Schwarzwald J, Solomon Z, Weisenberg M, Mikulincer M (1987): Validation of the impact of event scale for psychological sequelae of combat. J Consult Clin Psychol 55:251-256.
72. Shedler J, Mayman M, Manis M (1993): The Illusion of mental health. Am Psychol 48:1117-1131.
73. Simpson SA, Harding AE (1993): Predictive testing for Huntington's disease: After the gene. The United Kingdom Huntington's Disease Prediction Consortium. J Med Genet 30:1036-1038.
74. Tibben A, Vegter-van der Vlis M, Niermeijer MF, van de Kamp JJP, Roos RAC, Rooijmans HG, Frets PG, Verhage F (1990): Testing for Huntington's disease with support for all parties. Lancet 335:553.
75. Tibben A, Frets PG, van de Kamp JJP, Niermeijer MF, Vegter-van der Vlis M, Roos RAC, van Ommen GJB, Duivenvoorden HJ, Verhage F (1993a): Presymptomatic DNA-testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 48:10-16.
76. Tibben A, Frets PG, van de Kamp JJP, Niermeijer MF, Vegter-van der Vlis M, Roos RAC, Rooymans HG, van Ommen GJB, Verhage F (1993b): On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet 48:103-111.
77. Tibben A, Duivenvoorden HJ, Niermeijer MF, Vegter-van der Vlis M, Roos RAC, Verhage F (1994): Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 56:526-532.
78. Tibben A, Roos RAC, Niermeijer MF (1997a): Psychological consequences of presymptomatic testing for Huntington's disease. Lancet 349:809.
79. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ (1997b): 3-Year follow-up after presymptomatic testing for Huntington disease in tested individuals and partners. Health Psychol 16:20-35.
80. Walpole IR, Kool DA, Edkins T, Creegan R, Levitt S, Francis ST, Goldblatt J (1995): Genetic counseling and gene mutation analysis in familial adenomatous polyposis in Western Australia. Med J Aust 162:464-467.
81. Watson M, Lloyd SM, Eeles R, Ponder B, Easton D, Seal S, Averill D, Daly P, Ormiston W, Murday V (1996): Psychological impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting. Psycho-Oncology 5:233-239.
82. Wells S Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H (1994): Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220:237-247.
83. Wexler NS (1984): Huntington's disease and other late onset genetic disorders. In Emery AEH, Pullen IM (eds): "Psychological Aspects of Gentic Counselling." London: Academic Press, pp. 125-146.
84. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M, Sheps SB, Schechter MT, Hayden MR (1992): The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 327:1401-1405.
85. Wijnen J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer EJ, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Fodde R (1995): Seven new mutations in HMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060-1066.
86. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Allbright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR (1994): Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090.
87. Zigmond AS, Snaith RP (1983): The Hospital Anxiety and Depression Scale. Acta Psyhiatr Scand 67:361-370.
88. Zilberg NJ, Weiss DS, Horowitz MJ (1982): Impact of Event Scale: A cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol 50:407-414.